These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6791297)

  • 1. Effects of nifedipine (Adalat) on platelet function in vitro and in vivo.
    Johnsson H
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):523-8. PubMed ID: 6791297
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of platelet aggregation by a factor from Flavobacterium heparinum.
    Silbert CK; Nesbitt JP; Humphries DE; Silbert JE
    Thromb Res; 1985 Oct; 40(2):267-73. PubMed ID: 3934787
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris.
    Hiroki T; Inoue T; Yoshida T; Arakawa K
    Arzneimittelforschung; 1982; 32(12):1572-4. PubMed ID: 6891598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by ketamine hydrochloride.
    Atkinson PM; Taylor DI; Chetty N
    Thromb Res; 1985 Oct; 40(2):227-34. PubMed ID: 3934785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
    Akopov SE; Gabrielian ES
    Eur J Clin Pharmacol; 1992; 42(3):257-9. PubMed ID: 1577042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of urethane and thiopental sodium on platelet aggregation in vitro and in vivo.
    Evangelista S; Abelli L; Maggi CA; Meli A
    J Pharmacol Methods; 1984 Sep; 12(2):107-12. PubMed ID: 6443135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The suppressive effect of pyrrole-2-carboxylic acid on platelet aggregation].
    Komiyama K; Tronquet C; Hirokawa Y; Funayama S; Satoh O; Umezawa I; Oishi S
    Jpn J Antibiot; 1986 Mar; 39(3):746-50. PubMed ID: 3090299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects by nifedipine on thromboxane synthesis in vitro and in vivo.
    Davì G; Novo S; Fiore M; Foderà A; Mattina A; Mazzola A; Strano A
    Thromb Res; 1982 Dec; 28(6):837-42. PubMed ID: 6762684
    [No Abstract]   [Full Text] [Related]  

  • 9. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of co-dergocrine on platelet aggregation.
    Santos RO; Rodrigues R
    Braz J Med Biol Res; 1990; 23(3-4):325-7. PubMed ID: 2094545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nifedipine on platelet function.
    Takahara K; Kuroiwa A; Matsushima T; Nakashima Y; Takasugi M
    Am Heart J; 1985 Jan; 109(1):4-8. PubMed ID: 3155583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M; Landolfi R; Motola NC; Turcotte JG
    Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet function by injectable isosorbide dinitrate.
    De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
    Am J Cardiol; 1984 Jun; 53(11):1683-7. PubMed ID: 6428211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of graduated doses of nifedipine on ADP-induced platelet aggregation].
    Campa PP; Di Michele D; Paparoni S; De Curtis G; Fraioli A
    Boll Soc Ital Cardiol; 1980; 25(8):963-4. PubMed ID: 7284187
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of nifedipine on platelet aggregation due to ADP in the course of propranolol infusion].
    Di Michele D; Paparoni S; Moschetta D; De Curtis G; Campa PP
    Boll Soc Ital Cardiol; 1981; 26(12):2245-6. PubMed ID: 7185394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary studies of the effect of nifedipine on platelet aggregation induced with ADP].
    Campa PP; Di Michele D; Paparoni S; De Curtis G; Moschetta D
    Boll Soc Ital Cardiol; 1980; 25(3):225-30. PubMed ID: 7284127
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ketotifen and disodium cromoglycate on human platelet aggregation.
    García Mesa M; Arruzazabala Valmaña ML
    Allergol Immunopathol (Madr); 1989; 17(1):33-4. PubMed ID: 2502003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.